Legal status | |
---|---|
Legal status | |
Identifiers | |
| |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C23H29FN2O2 |
Molar mass | 384.495 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
S-17092 is a drug which acts as a selective inhibitor of the enzyme prolyl endopeptidase. [1] This enzyme is involved in the metabolic breakdown of a number of neuropeptide neurotransmitters in the brain, [2] [3] and so inhibiting the action of the enzyme increases the activity of these neuropeptides. This produces nootropic effects which make S-17092 a promising and novel treatment for neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease. [4] [5]
Legal status | |
---|---|
Legal status | |
Identifiers | |
| |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C23H29FN2O2 |
Molar mass | 384.495 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
S-17092 is a drug which acts as a selective inhibitor of the enzyme prolyl endopeptidase. [1] This enzyme is involved in the metabolic breakdown of a number of neuropeptide neurotransmitters in the brain, [2] [3] and so inhibiting the action of the enzyme increases the activity of these neuropeptides. This produces nootropic effects which make S-17092 a promising and novel treatment for neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease. [4] [5]